CARDIOSTIM-EHRA EUROPACE Highlights

flipper_slider

Editor's Choice

Joachim Ehrlich discusses the BRIDGE study and its findings, and how they will be applicable to patients taking new oral anticoagulants rather than warfarin. Disclosures: Joachim Ehrlich has participated in...

CARDIOSTIM-EHRA EUROPACE Highlights Videos

Tom de Potter explores the advantages and disadvantages of a standard approach to ablation paroxysmal atrial fibrillation. FILMED AT THE CARDIOSTIM ANNUAL MEETING, JUNE 2016 WHAT ARE THE ADVANTAGES AND DISADVANTAGES OF A STANDARD APPROACH TO ABLATION IN PAF? 00:12 – Ablation for PAF has been...
Moloy Das discusses the aims and findings of the PRESSURE trial. Disclosures: Moloy Das has no relationships to declare, FILMED AT THE CARDIOSTIM ANNUAL MEETING, JUNE 2016 WHAT ARE THE CURRENT LIMITATIONS OF CATHETER ABLATION FOR AF? 00:11 – Well I think there are two main limitations...
Richard Schilling describes the cryoballoon technique for atrial fibrillation ablation and the advantages of this technique over radiofrequency ablation. FILMED AT THE CARDIOSTIM ANNUAL MEETING, JUNE 2016 COULD YOU DESCRIBE THE CRYOBALLOON TECHNIQUE FOR ATRIAL FIBRILLATION ABLATION? 00:11 – So...
Pier Lambiase discusses patient selection for cardiac resynchronisation therapy and the current research into personalised computer models of the heart. Disclosures: Pier Lambiase has received research grants and speaker fees from Boston Scientific and educational grants from Medtronic and St...
Luca Bontempi discusses the challenges of resynchronisation therapy in the elderly along with some of the hot topics in cardiac rhythm management from this year’s meeting. FILMED AT THE CARDIOSTIM ANNUAL MEETING, JUNE 2016 WHAT ARE THE CHALLENGES OF RESYNCHRONISATION THERAPY IN THE ELDERLY? 00...
Haran Burri discusses the remote monitoring of cardiac resynchronisation therapy, the ACUITY X4 multipolar leads and the outcomes of the RALLY-X4 study. FILMED AT THE CARDIOSTIM ANNUAL MEETING, JUNE 2016 WHAT ARE THE ADVANTAGES OF THE ACUITY X4 MULTIPOLAR LEADS? 00:10 – So these are...
Jose Merino gives an overview of the ENSURE-AT and EMANATE trials along with future studies planned for new oral anticoagulants (NOACs). Disclosures: Jose Merino has received consultory and speaker fees from Daiichi-Sankyo, Bayer, BMS, Boheringhe, Sanofi and Cardiome. FILMED AT THE CARDIOSTIM...
Claudio Tondo explores the major unmet needs in stroke prophylaxis in atrial fibrillation. Disclosures: Claudio Tondo has no conflict of interest to disclose. FILMED AT THE CARDIOSTIM ANNUAL MEETING, JUNE 2016 WHAT ARE THE MAJOR UMET NEEDS IN STROKE PROPHYLAXIS IN AF? 00:10 – Nowadays I do...
Joachim Ehrlich discusses the BRIDGE study and its findings, and how they will be applicable to patients taking new oral anticoagulants rather than warfarin. Disclosures: Joachim Ehrlich has participated in speakers' bureau for Bayer, Boehringer, BMS, Pfizer and Daichi Sankyo. FILMED AT THE...